Recent Finacing
Recent Raise
Dicerna develops Dicer Substrate RNAi therapeutics and targeted delivery platforms—DsiRNA, EnCore and lipid nanoparticle and conjugate systems—to advance oncology and other preclinical programs into clinical development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors